Vision Medicines

About:

Vision Medicines is a promising drug candidate to treat Stargardt disease.

Website: http://visionmedicines.com/

Description:

Vision Medicines has a promising drug candidate to treat Stargardt disease, a rare genetic retinal degenerative disease, and other rare diseases caused by inborn errors of aldehyde metabolism. Vision Medicines has recruited a world-class scientific advisory board that includes leading scientists and clinicians specializing in retinal biology and genetics.

Total Funding Amount:

$7.5M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2013-01-01

Founders:

Brinda Balakrishnan, Chris Varma, Reza Dana

Number of Employees:

11-50

Last Funding Date:

2015-11-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai